Insiders Shanghai Henlius Biotech, Inc.

Equities

2696

CNE100003N76

Delayed Hong Kong S.E. Other stock markets 07:44:06 14/05/2024 am IST			5-day change	1st Jan Change
17.26 ^HKD	+0.23%		+3.61%	+23.88%

06/05	Henlius Biotech Gets US FDA Clearance for Phase 3 Trial of Gastric Cancer Combination Therapy	MT
06/05	Shanghai Henlius Biotech, Inc. Announces Application for the Phase 3 Clinical Trial of HLX22 in Combination with Trastuzumab and Chemotherapy as the First-Line Treatment of HER2 Positive Advanced Gastric Cancer Approved by the United States Food and Drug Administration	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Henlius Biotech Names New President	03/23/03	MT
Shanghai Henlius Biotech, Inc. Appoints Wei Huang as President	03/23/03	CI
Shanghai Henlius Biotech, Inc. Announces Executive Appointments	28/23/28	CI
Shanghai Henlius Biotech, Inc. Announces Chief Executive Officer Changes	17/23/17	CI
Shanghai Henlius Biotech, Inc. Announces Resignation of Zihou Yan as Non-Executive Director, Member of the Strategy Committee and Environmental, Social and Governance Committee	17/23/17	CI
Shanghai Henlius Biotech CFO/Vice President Resigns	02/23/02	MT
Shanghai Henlius Biotech, Inc. Announces Executive Changes	18/22/18	CI
Henlius Biotech Reappoints Chairman/CEO	29/22/29	MT
Shanghai Henlius Biotech, Inc. Appoints Deyong Wen as a Non-Executive Director	28/22/28	CI
Shanghai Henlius Biotech, Inc. Announces Retirement of Aimin Hui as Non-Executive Director	30/22/30	CI
Shanghai Henlius Biotech Rejigs Top-Level Management	01/21/01	MT
Shanghai Henlius Biotech, Inc. Announces Board Changes	30/21/30	CI
Shanghai Henlius Biotech, Inc. Announces Change of Joint Company Secretary	05/21/05	CI
Shanghai Henlius Biotech, Inc. Announces Board Changes	31/20/31	CI
Shanghai Henlius Biotech, Inc. Appoints Wenjie Zhang as Executive Director	19/20/19	CI
Shanghai Henlius Biotech, Inc. Announces Change of Executive Director	30/20/30	CI
Shanghai Henlius Biotech, Inc. Announces Change of Chief Executive Officer	30/20/30	CI
Shanghai Henlius Biotech, Inc. Appoints Rongli Feng as Chairman of the Board of Supervisors	24/20/24	CI
Shanghai Henlius Biotech, Inc. Announces Kun Dai Has Tendered Her Resignation as A Supervisor	24/20/24	CI
Shanghai Henlius Biotech, Inc. Announces Executive Changes	19/20/19	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Shanghai Henlius Biotech, Inc.

Equities

2696

CNE100003N76

Insiders

Filters